A detailed history of Callan Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Callan Capital, LLC holds 2,736 shares of AMGN stock, worth $805,834. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,736
Previous 2,649 3.28%
Holding current value
$805,834
Previous $827,000 6.53%
% of portfolio
0.06%
Previous 0.07%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$309.38 - $337.38 $26,916 - $29,352
87 Added 3.28%
2,736 $881,000
Q2 2024

Aug 12, 2024

BUY
$262.75 - $319.31 $7,094 - $8,621
27 Added 1.03%
2,649 $827,000
Q1 2024

Oct 22, 2024

SELL
$268.87 - $324.56 $7,259 - $8,763
-27 Reduced 1.02%
2,622 $745,000
Q1 2024

May 03, 2024

BUY
$268.87 - $324.56 $31,188 - $37,648
116 Added 4.63%
2,622 $745,000
Q4 2023

Feb 02, 2024

BUY
$255.7 - $288.46 $35,030 - $39,519
137 Added 5.78%
2,506 $721,000
Q3 2023

Nov 06, 2023

BUY
$218.65 - $271.46 $28,643 - $35,561
131 Added 5.85%
2,369 $636,000
Q2 2023

Aug 04, 2023

BUY
$214.27 - $253.37 $5,785 - $6,840
27 Added 1.22%
2,238 $496,000
Q1 2023

Jun 13, 2023

BUY
$225.79 - $275.2 $1,354 - $1,651
6 Added 0.27%
2,211 $534,000
Q1 2023

May 08, 2023

BUY
$225.79 - $275.2 $1,354 - $1,651
6 Added 0.27%
2,211 $534,000
Q4 2022

Jun 13, 2023

SELL
$229.03 - $291.01 $1,374 - $1,746
-6 Reduced 0.27%
2,205 $579,000
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $215,288 - $273,549
940 Added 74.31%
2,205 $579,000
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $58,359 - $65,819
260 Added 25.87%
1,265 $285,000
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $69,674 - $77,535
-302 Reduced 23.11%
1,005 $245,000
Q1 2022

May 10, 2022

SELL
$219.27 - $242.57 $76,744 - $84,899
-350 Reduced 21.12%
1,307 $316,000
Q4 2021

Jan 21, 2022

BUY
$198.88 - $227.6 $70,005 - $80,115
352 Added 26.97%
1,657 $373,000
Q3 2021

Oct 15, 2021

BUY
$212.27 - $248.7 $8,490 - $9,948
40 Added 3.16%
1,305 $278,000
Q1 2021

May 10, 2021

BUY
$221.91 - $258.6 $57,696 - $67,236
260 Added 25.87%
1,265 $315,000
Q1 2020

May 08, 2020

BUY
$182.24 - $241.7 $183,151 - $242,908
1,005 New
1,005 $204,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Callan Capital, LLC Portfolio

Follow Callan Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Capital, LLC with notifications on news.